逆转 2 型糖尿病：生活方式医学的时代已经到来！
Reversing Type 2 Diabetes: The Time for Lifestyle Medicine Has Come!
机构信息
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Québec, QC G1V 4G5, Canada.
出版信息
Nutrients. 2020 Jul 3;12(7):1974. doi: 10.3390/nu12071974.
Abstract
The IDF (International Diabetes Federation) Diabetes Atlas Committee has recently published the global estimates of diabetes prevalence for 2019 [...].
摘要
国际糖尿病联合会（IDF）糖尿病地图集委员会最近发布了 2019 年全球糖尿病患病率的估计值[... ]。
相似文献
1
Reversing Type 2 Diabetes: The Time for Lifestyle Medicine Has Come!逆转 2 型糖尿病：生活方式医学的时代已经到来！
Nutrients. 2020 Jul 3;12(7):1974. doi: 10.3390/nu12071974.
2
Lifestyle-based precision medicine for reducing diabetes incidence in people with prediabetes.基于生活方式的精准医学用于降低糖尿病前期人群的糖尿病发病率。
Prim Care Diabetes. 2022 Feb;16(1):215. doi: 10.1016/j.pcd.2021.12.001. Epub 2021 Dec 30.
3
Diabetes in the Elderly: A Silent Global Tsunami.老年糖尿病：一场无声的全球海啸。
Can J Diabetes. 2016 Feb;40(1):2-3. doi: 10.1016/j.jcjd.2015.12.003. Epub 2016 Jan 6.
4
Using Digital Health Technology to Prevent and Treat Diabetes.利用数字健康技术预防和治疗糖尿病。
Diabetes Technol Ther. 2017 Feb;19(S1):S59-S73. doi: 10.1089/dia.2017.2506.
5
By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012.数据显示：国际糖尿病联盟《2012年糖尿病地图更新版》的新估计数。
Diabetes Res Clin Pract. 2012 Dec;98(3):524-5. doi: 10.1016/j.diabres.2012.11.006.
6
[Not Available].[无可用内容]
Ther Umsch. 2016;73(6):340-8. doi: 10.1024/0040-5930/a000802.
7
The COVID-19 lockdown as an opportunity to change lifestyle and body weight in people with overweight/obesity and diabetes: Results from the national French COVIDIAB cohort.新冠疫情封锁期为超重/肥胖和糖尿病患者改变生活方式和体重提供了机会：来自法国全国 COVIDIAB 队列的研究结果。
Nutr Metab Cardiovasc Dis. 2021 Aug 26;31(9):2605-2611. doi: 10.1016/j.numecd.2021.05.031. Epub 2021 Jun 17.
8
Tips for Facilitating Lifestyle Changes in Low-Income Communities.促进低收入社区生活方式改变的小贴士。
Am Fam Physician. 2018 Jul 1;98(1):10.
9
Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies.沙特阿拉伯 2 型糖尿病患病率预估的比较：基于经过验证的马尔可夫模型与国际糖尿病联合会和其他建模研究的比较。
Diabetes Res Clin Pract. 2014 Mar;103(3):496-503. doi: 10.1016/j.diabres.2013.12.036. Epub 2014 Jan 3.
10
Prediabetes management in the Middle East, Africa and Russia: Current status and call for action.中东、非洲和俄罗斯的糖尿病前期管理：现状与行动呼吁。
Diab Vasc Dis Res. 2019 May;16(3):213-226. doi: 10.1177/1479164118819665. Epub 2019 Jan 3.
引用本文的文献
1
Kidney Gastrin/CCKBR Attenuates Type 2 Diabetes Mellitus by Inhibiting SGLT2-Mediated Glucose Reabsorption through Erk/NF-κB Signaling Pathway.肾脏胃泌素/胆囊收缩素B受体通过Erk/NF-κB信号通路抑制SGLT2介导的葡萄糖重吸收来减轻2型糖尿病。
Diabetes Metab J. 2025 Mar;49(2):194-209. doi: 10.4093/dmj.2023.0397. Epub 2024 Dec 24.
2
The Role of Fenugreek in the Management of Type 2 Diabetes.葫芦巴在 2 型糖尿病管理中的作用。
Int J Mol Sci. 2024 Jun 26;25(13):6987. doi: 10.3390/ijms25136987.
3
The forgotten patient: A psychological perspective on the implementation of bariatric surgery guidelines.被遗忘的患者：对减肥手术指南实施的心理学视角
Obes Sci Pract. 2023 Apr 5;9(5):538-547. doi: 10.1002/osp4.670. eCollection 2023 Oct.
4
The Description and Prediction of Incidence, Prevalence, Mortality, Disability-Adjusted Life Years Cases, and Corresponding Age-Standardized Rates for Global Diabetes.全球糖尿病发病率、患病率、死亡率、伤残调整生命年病例数的描述和预测及其年龄标准化率。
J Epidemiol Glob Health. 2023 Sep;13(3):566-576. doi: 10.1007/s44197-023-00138-9. Epub 2023 Jul 3.
5
Diosgenin Ameliorated Type II Diabetes-Associated Nonalcoholic Fatty Liver Disease through Inhibiting De Novo Lipogenesis and Improving Fatty Acid Oxidation and Mitochondrial Function in Rats.薯蓣皂苷元通过抑制从头合成脂和改善脂肪酸氧化和线粒体功能来改善大鼠 2 型糖尿病相关的非酒精性脂肪性肝病。
Nutrients. 2022 Nov 24;14(23):4994. doi: 10.3390/nu14234994.
6
Deciphering the Variants Located in the , , and with Type-2 Diabetes Mellitus in Pakistani Population.解析巴基斯坦人群中 2 型糖尿病相关的 、 、 位置的变异。
Genes (Basel). 2021 Apr 28;12(5):664. doi: 10.3390/genes12050664.
本文引用的文献
1
Negative Energy Balance Induced by Exercise or Diet: Effects on Visceral Adipose Tissue and Liver Fat.运动或饮食引起的负能平衡：对内脏脂肪组织和肝脂肪的影响。
Nutrients. 2020 Mar 25;12(4):891. doi: 10.3390/nu12040891.
2
Comparison of the effect of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.比较 Roux-en-Y 胃旁路术和袖状胃切除术对 2 型糖尿病缓解效果的随机对照试验的系统评价和荟萃分析。
Obes Rev. 2020 Jun;21(6):e13011. doi: 10.1111/obr.13011. Epub 2020 Mar 11.
3
Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss.肝脂蛋白输出与减肥后人类 2 型糖尿病的缓解
Cell Metab. 2020 Feb 4;31(2):233-249.e4. doi: 10.1016/j.cmet.2019.11.018. Epub 2019 Dec 19.
4
Predicting longevity using metabolomics: a novel tool for precision lifestyle medicine?利用代谢组学预测寿命：精准生活方式医学的新工具？
Nat Rev Cardiol. 2020 Feb;17(2):67-68. doi: 10.1038/s41569-019-0310-2.
5
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition.2019 年全球及各区域糖尿病患病率估算值及 2030 年和 2045 年预测值：国际糖尿病联盟糖尿病地图集（第 9 版）的结果。
Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843. Epub 2019 Sep 10.
6
Behaviour change, weight loss and remission of Type 2 diabetes: a community-based prospective cohort study.行为改变、体重减轻与 2 型糖尿病缓解：基于社区的前瞻性队列研究。
Diabet Med. 2020 Apr;37(4):681-688. doi: 10.1111/dme.14122. Epub 2019 Sep 26.
7
Reply to "Utility of Unrefined Carbohydrates in Type 2 Diabetes. Comment on Reversing Type 2 Diabetes: A Narrative Review of the Evidence, , 2019, , 766".回复“2 型糖尿病中未精制碳水化合物的效用。评论：逆转 2 型糖尿病：对证据的叙述性回顾，2019 年，，766”。
Nutrients. 2019 Jul 18;11(7):1644. doi: 10.3390/nu11071644.
8
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.内脏和异位脂肪、动脉粥样硬化和代谢性心血管疾病：立场声明。
Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725. doi: 10.1016/S2213-8587(19)30084-1. Epub 2019 Jul 10.
9
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2018 年美国糖尿病协会（ADA）和欧洲糖尿病研究协会（EASD）共识报告：2 型糖尿病患者高血糖管理。
Diabetes Care. 2018 Dec;41(12):2669-2701. doi: 10.2337/dci18-0033. Epub 2018 Oct 4.
10
Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery.2 型糖尿病的缓解需要降低肝脏和胰腺脂肪含量，但这取决于β细胞的恢复能力。
Cell Metab. 2018 Oct 2;28(4):547-556.e3. doi: 10.1016/j.cmet.2018.07.003. Epub 2018 Aug 2.
Zotero 插件